Welcome to the ATS Assembly on Pulmonary Infections and Tuberculosis account. Follow us to discover latest research and Assembly updates!
Joined February 2015
- Tweets914
- Following472
- Followers710
- Likes321
Determining antibiotic duration in critically ill patients remains challenging. This narrative review synthesizes the evidence to guide decisions on short-course versus extended therapy. #AJRCCM
doi.org/10.1093/ajrccm/aamag…
This descriptive analysis, recently published in #AnnalsATS, examines bronchiectasis prevalence, incidence, exacerbation rates, and associated risk factors among insured U.S. adults from 2016 to 2024. #Bronchiectasis
doi.org/10.1093/annalsats/aa…
🎤🫁 Check out our latest podcast featuring Dr. Jerry Zifodya, discussing his latest publication, “Clinical and Transcriptomic Risk Factors for Post-Tuberculosis Lung Disease in a Cohort of Kenyan Adults.”
assemblies-and-sections.tran…
ATS PI-TB Assembly retweeted
So much fun discussing medicine with two of my favorite people in the bronchiectasis world! We will be taking a deep dive into the clinical practice guidelines for Bronchiectasis and how the landscape is rapidly changing. Come join us! @ProfJDChalmers @ATS_PITB #bronchiectasis
🌲2 days to go!
🚨Join us for a discussion on bronchiectasis management with Drs. James D. Chalmers & Timothy Aksamit, covering the ERS & CHEST guidelines.
⭐️Case presented by Emma Johnson
⭐️Moderated by Dr. Divya Reddy
@direddy @ProfJDChalmers
thoracic.zoom.us/webinar/reg…
🌲2 days to go!
🚨Join us for a discussion on bronchiectasis management with Drs. James D. Chalmers & Timothy Aksamit, covering the ERS & CHEST guidelines.
⭐️Case presented by Emma Johnson
⭐️Moderated by Dr. Divya Reddy
@direddy @ProfJDChalmers
thoracic.zoom.us/webinar/reg…
ATS PI-TB Assembly retweeted
Come on thursday to hear the AMAZING Emma Johnson, Me and Tim Aksamit talk about state of the art management of bronchiectasis
Chaired by the awesome Divya Reddy
Team bronchiectasis @ATS_PITB
🚨 Mark your calendars for our next
🌲PINE🌲 Webinar!
🫁 Bronchiectasis Management Reimagined: Key Updates from the 2025 ERS Guidelines
Case-based discussion with global experts 🌍
🗓️ Sep 17 |⏱️ 11 AM ET
📝 Register here: thoracic.zoom.us/webinar/reg…
@ATS_Assemblies @EuroRespSoc
🌺 The next chapter in NTM lung disease is being written in the Pacific!
Join the NTM & bronchiectasis community in Honolulu for the HAPA NTM & Bronchiectasis Conference.
📅 March 8–10, 2027
📍 Honolulu, Hawaiʻi
🔗 NTMHawaii.org
🚨 Mark your calendars for our next
🌲PINE🌲 Webinar!
🫁 Bronchiectasis Management Reimagined: Key Updates from the 2025 ERS Guidelines
Case-based discussion with global experts 🌍
🗓️ Sep 17 |⏱️ 11 AM ET
📝 Register here: thoracic.zoom.us/webinar/reg…
@ATS_Assemblies @EuroRespSoc
🗞️ Check out our August PI-TB Newsletter! 🫁🦠
Catch up on the latest infection-related ATS articles, upcoming deadlines and events, Assembly updates, and more.
craftprd1.blob.core.windows.…
ATS PI-TB Assembly retweeted
ERJ Open Research: In MAHALE, benralizumab did not improve bronchiectasis clinical outcomes. Adequately powered randomised trials are needed in the population of interest. bit.ly/4dFjR40
🫁A CAP wish-list: top research priorities from the CAP Research Priority Setting Partnership (PSP)
sciencedirect.com/science/ar…
🫁In 310 adults hospitalized with Legionella pneumonia, each 6-hour delay to Legionella-active therapy was associated with 11% higher adjusted odds of 90-day mortality. Median time to effective therapy was significantly longer in immunocompromised hosts 🫁
academic.oup.com/annalsats/a…
🦠New prospective data challenge the assumption that post-TB lung disease is limited to pulmonary TB: adults successfully treated for extrapulmonary TB had persistent spirometric impairment and respiratory symptoms for 1.5 years. 🫁
academic.oup.com/ajrccm/arti…
From #AnnalsATS: Among critically ill adults undergoing BAL for suspected pneumonia, clinical assessment alone often disagreed with BAL-informed adjudication, with overdiagnosis slightly more common than missed pneumonia.
academic.oup.com/annalsats/a…
ATS PI-TB Assembly retweeted
Post-tuberculosis lung disease in treated extra-pulmonary tuberculosis
Not just post-TB: extra-pulmonary tuberculosis cases can have lasting lung impairment after treatment. Expanding post-TB screening is critical
doi.org/10.1093/ajrccm/aamag…
@atscommunity
🥳Happy Friday!
A fun case of a rare pulmonary complication following fungal infections. Would you have guessed?
doi.org/10.1093/annalsats/aa…
#pulmonary #ATS @AnnalsATS @atscommunity
🫁 Not all post-TB lung disease is biologically the same.
Distinct transcriptomic signatures in restrictive vs. obstructive post-TB lung disease—could this enable more precise therapies?
doi.org/10.1093/ajrccm/aamag…
#tuberculosis #pulmonary #ATS @atscommunity
ATS PI-TB Assembly retweeted
The American Thoracic Society (ATS) strongly opposes the White House’s new executive order affecting federal childhood vaccine policy.
“This action is not grounded in scientific evidence and risks further eroding public confidence in the safety of routinely recommended childhood immunizations.
The executive order directly affects prevention of influenza, COVID-19, and RSV, respiratory infections that can cause severe illness, hospitalization, respiratory failure, and death, particularly among children with underlying lung disease or other medical vulnerabilities.
The order will result in delays, lower vaccination rates among U.S. children, and more disease outbreaks.” - Tina Hartert, MD, MPH, co-chair, ATS Vaccine Initiative Advisory Panel.
The ATS will continue to advocate for evidence-based, public health-focused approach to childhood vaccination policy.
📢 Know a colleague who would be a great Assembly leader? Nominate them for a leadership position!
🗓️ Deadline: September 4
👉 surveymonkey.com/r/KQHMZL8?u…